Updated guidelines on the Valneva SARS-CoV-2 vaccine
The WHO provides interim guidelines for the use of the Valneva vaccine.
Source: news-medical.net
Page 12 - Agonist News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Agonist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Agonist Today - Breaking & Trending Today
A Novel Drug Suppresses Muscle Inflammation And Restores Muscle Weakness
Inflammatory myopathies can be challenging to treat, but a new study reports encouraging findings for patients with these debilitating conditions. Researchers from Japan have found that a novel member of a class of anti-diabetes drugs could be the key to treating patients with muscle wasting disease.
Source: news-medical.net
PET imaging could help measure the pharmacodynamic effects of using STING-activating drugs
Stimulator of interferon genes, or STING, helps regulate immune activation. Thus, drugs that activate STING are being tested as a form of cancer immunotherapy and for treating certain infections.
Source: news-medical.net
SARS-CoV-2 receptor-binding domain-based protein subunit vaccine shows promise against multiple SARS-CoV-2 variants
Researchers described a novel protein subunit vaccine comprising the receptor-binding domain (RBD) of ancestral SARS-CoV-2 spike (S) protein, dimerized with an immunoglobulin (Ig)G1-fraction, crystallizable (Fc) domain.
Source: news-medical.net
Exelixis, Inc.: Exelixis and Ryvu Therapeutics Establish Exclusive License Agreement to Develop Novel STING Agonist-Based Targeted Cancer Therapies
Provides additional opportunity for Exelixis to further expand its biotherapeutics development pipeline by combining its tumor-specific targeting approaches with Ryvu's STING agonist technology, which
Source: finanznachrichten.de